Clinical Trials, Data Security Among US Federal Enforcement Priorities
Executive Summary
Pandemic-related fraud, advertising to children, and corporate compliance programs are among the issues that were highlighted during a recent webinar.
You may also be interested in...
With Roe v. Wade In Rearview, What’s Next For Women’s Health?
Manufacturers of devices and apps focused on reproductive health are still feeling out the import of a recent US Supreme Court decision overturning the federal right to abortion. Some attorneys say the ramifications may be vast.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.